Under the revised agreement, the two have taken their RSV commitment a step forward as Zhifei agrees to engage exclusively ...

UK pharma major GSK has into an agreement with Chongqing Zhifei Biological Products (Zhifei) to revize the terms on which ...

GSK expands the licensing deal with Zhifei to market its shingles vaccine in China for an additional eight years till 2034.

GSK and Zhifei revise and extend strategic vaccine collaboration in China: London, UK Friday, December 6, 2024, 10:00 Hrs [IST] GSK plc announced that it has entered into an agree ...

GSK plc GSK announced that it has revised its collaboration deal with Chongqing Zhifei Biological Products (Zhifei), China's largest vaccine maker, to co-market its shingles vaccine Shingrix in ...

Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This briefing covers significant developments in health, including a revised deal between GSK and China's Zhifei, FDA ...